EP3585396A4 - Compounds, compositions and methods for prevention or treatment of liver, lipid, and glucose-related conditions - Google Patents

Compounds, compositions and methods for prevention or treatment of liver, lipid, and glucose-related conditions Download PDF

Info

Publication number
EP3585396A4
EP3585396A4 EP18756987.6A EP18756987A EP3585396A4 EP 3585396 A4 EP3585396 A4 EP 3585396A4 EP 18756987 A EP18756987 A EP 18756987A EP 3585396 A4 EP3585396 A4 EP 3585396A4
Authority
EP
European Patent Office
Prior art keywords
lipid
liver
glucose
prevention
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP18756987.6A
Other languages
German (de)
French (fr)
Other versions
EP3585396A1 (en
Inventor
Nallagounder KUPPUSAMY
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sivanaray Inc
Original Assignee
Sivanaray Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sivanaray Inc filed Critical Sivanaray Inc
Publication of EP3585396A1 publication Critical patent/EP3585396A1/en
Publication of EP3585396A4 publication Critical patent/EP3585396A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP18756987.6A 2017-02-21 2018-02-20 Compounds, compositions and methods for prevention or treatment of liver, lipid, and glucose-related conditions Withdrawn EP3585396A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762461678P 2017-02-21 2017-02-21
PCT/US2018/018806 WO2018156513A1 (en) 2017-02-21 2018-02-20 Compounds, compositions and methods for prevention or treatment of liver, lipid, and glucose-related conditions

Publications (2)

Publication Number Publication Date
EP3585396A1 EP3585396A1 (en) 2020-01-01
EP3585396A4 true EP3585396A4 (en) 2020-11-25

Family

ID=63252985

Family Applications (1)

Application Number Title Priority Date Filing Date
EP18756987.6A Withdrawn EP3585396A4 (en) 2017-02-21 2018-02-20 Compounds, compositions and methods for prevention or treatment of liver, lipid, and glucose-related conditions

Country Status (3)

Country Link
US (1) US20200009169A1 (en)
EP (1) EP3585396A4 (en)
WO (1) WO2018156513A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109679946B (en) * 2019-01-04 2020-11-13 宁波艾捷康宁生物科技有限公司 Blood virus RNA protective agent and blood collection tube
CN111700902B (en) * 2020-07-16 2022-02-22 河北农业大学 Hawthorn procyanidine-jujube polysaccharide composition and preparation method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120276208A1 (en) * 2011-04-27 2012-11-01 University Of South Australia Acute cognitive and mood effects of plant polysaccharides in adult human subjects
WO2017023703A1 (en) * 2015-07-31 2017-02-09 Sivanaray, Inc. Compounds, compositions and methods for prevention or treatment of liver and lipid-related conditions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100438878C (en) * 2002-08-30 2008-12-03 中国科学院上海有机化学研究所 Active largehead atractylodes saccharide complex for reducing blood sugar and its prepn and use
KR100544052B1 (en) * 2003-10-31 2006-01-23 주식회사 엠디바이오알파 Polysaccharides Of Plants Belonging To Panax Having Effect On Treatment And Prevention Of Obesity
CN105326880A (en) * 2015-11-25 2016-02-17 江苏康缘药业股份有限公司 Rape pollen water soluble extract as well as preparation method and application thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120276208A1 (en) * 2011-04-27 2012-11-01 University Of South Australia Acute cognitive and mood effects of plant polysaccharides in adult human subjects
WO2017023703A1 (en) * 2015-07-31 2017-02-09 Sivanaray, Inc. Compounds, compositions and methods for prevention or treatment of liver and lipid-related conditions

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
INOUE S ET AL: "EFFECT OF L-ARABINOSE ON BLOOD GLUCOSE LEVEL AFTER INGESTION OF SUCROSE-CONTAINING FOOD IN HUMAN", NIPPON EIYO SHOKURYO GAKKAISHI - JOURNAL OF JAPANESE SOCIETY OFNUTRITION AND FOOD SCIENCE, TOKYO, JP, vol. 53, no. 6, 1 January 2000 (2000-01-01), pages 243 - 247, XP002906378, ISSN: 0287-3516 *
See also references of WO2018156513A1 *

Also Published As

Publication number Publication date
US20200009169A1 (en) 2020-01-09
WO2018156513A1 (en) 2018-08-30
EP3585396A1 (en) 2020-01-01

Similar Documents

Publication Publication Date Title
EP3679141A4 (en) Methods and compositions for inhibiting expression of ldha
EP3481402A4 (en) Compounds, compositions, and methods for the treatment of disease
EP3675859A4 (en) Compounds, compositions, and methods for the treatment of disease
EP3294761A4 (en) Compositions and methods for treatment and prevention of uropathogenice. coli
EP3810109A4 (en) Compositions and methods for inhibiting cd73
EP3399993A4 (en) Methods and compositions for the prevention and treatment of duchenne muscular dystrophy
EP3720421A4 (en) Compositions and methods for the treatment of metabolic conditions
EP3426349A4 (en) Methods and compositions for inhibiting pmp22 expression
EP3471722A4 (en) Compounds, compositions and methods for prevention and/or treatment of cancer
EP3675858A4 (en) Compounds and compositions for ire1 inhibition
EP3310783A4 (en) Methods and compositions for the prevention and treatment of hearing loss
EP3445450A4 (en) Method of treating or preventing liver conditions
EP3236993A4 (en) Methods and compositions for inhibiting or preventing adverse effects of oral antibiotics
EP3344256A4 (en) Compositions for the treatment of joints
EP3522899A4 (en) Compounds and compositions for treating leishmaniasis and methods of diagnosis and treating using same
EP3687628A4 (en) Compositions and methods for inhibiting acss2
EP3675632A4 (en) Methods and compositions for the preservation of tissue
EP3391881A4 (en) Pharmaceutical composition for preventing or treating fatty liver
EP3203999A4 (en) Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis
EP3341006A4 (en) Compositions and methods for the treatment of neurodamage
EP3277269A4 (en) Methods for prevention and treatment of cardiometabolic syndrome and compositions used therein
EP3203992A4 (en) Compositions and methods for increasing the bioavailability of one or more compounds
EP3618846A4 (en) Methods and compositions for treating liver disease
EP3328392A4 (en) Compounds, compositions and methods for prevention or treatment of liver and lipid-related conditions
EP3585396A4 (en) Compounds, compositions and methods for prevention or treatment of liver, lipid, and glucose-related conditions

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20190920

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20201028

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 3/10 20060101ALI20201022BHEP

Ipc: A61K 9/20 20060101ALI20201022BHEP

Ipc: A61K 9/48 20060101ALI20201022BHEP

Ipc: A61K 31/7004 20060101ALI20201022BHEP

Ipc: A61K 31/7012 20060101AFI20201022BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20210528